H Ni, SZ Aye, C Naing - Cochrane Database of Systematic …, 2022 - cochranelibrary.com
Background Chronic obstructive pulmonary disease (COPD) is a chronic and progressive disease, often punctuated by recurrent flare‐ups or exacerbations. Magnesium sulfate …
BM Zanforlini, C Ceolin, C Trevisan, A Alessi… - Aging clinical and …, 2022 - Springer
Background and aims COPD is a common chronic condition in older age that impacts on daily activities and quality of life. Previous studies suggest that magnesium deficit in COPD …
M Fekete, A Lehoczki, T Csípő, V Fazekas-Pongor… - Nutrients, 2024 - mdpi.com
Background: Chronic obstructive pulmonary disease (COPD) is a progressive, inflammatory airway disorder characterized by a gradual decline in lung function and increased oxidative …
HU Bhatti, Z Mushtaq, A Arshad, N Khanum… - Pak J Med Health …, 2021 - pjmhsonline.com
Magnesium revealed to have properties of bronchodilation in chronic obstructive pulmonary disease (COPD) and asthma. A clinical benefit of nebulization with magnesium has been …
NS Selvam, K Girish, S Priyanka, R Jyothi… - National Journal of …, 2024 - njppp.com
Background: Acute exacerbations of chronic obstructive pulmonary diseases (AECOPD) are a frequent cause of hospitalization, morbidity, and mortality and require serious medical …
M Naguib, NA Saad, M Farouk Mohammad… - Bulletin of …, 2024 - journals.ekb.eg
Aim: To assess the effectiveness and Safety of the recommended dosage of magnesium sulfate (MgSO4), 2000 mg, administered via nebulizer and intravenous routes, when added …
TW Silva, C Valerio, B Gawrys - American Family Physician, 2022 - aafp.org
Conclusion: A color recommendation of yellow (unclear benefits) was assigned for the use of magnesium sulfate infusion to prevent hospital admission from the ED for acute COPD …